Cybin stock soars after announcing $175 million registered offering By Investing.com
Update: 2025-10-28
Description
Cybin Inc. secures $175 million in funding, led by high-profile biotech investors, to pay off debts and advance its Phase 3 clinical trials for innovative mental health treatments.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel




